Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > New Management can't come soon enough
View:
Post by SmallBets on Jan 13, 2022 12:30pm

New Management can't come soon enough

in any business, no matter what position you're in;  you are accountable.  ok, the science is decent here.  nothing licenses or approved, but looks promising.
the business side... speaks for itself.
i voted against this team last time.
i hope more do next time
Comment by MustangSalley on Jan 13, 2022 1:57pm
Small bets, Last year AGM I encouraged everybody to vote against the compensation package of 48 millions dsu option shares . It was argued that they were needed to entice new hires . So far 7 million to Spillup, 5 million to Swetlow ( CFO that is Matthews Buddy' and lots to Frank Hollar) . Science is good . Management not so good....  Everything can be corrected with a pharma deal that ...more  
Comment by BioTeck on Jan 13, 2022 7:16pm
I also voted against DSU. If I'm still in the stock next year, I'll definitely vote against them all. Uncle Spill, hit us up with a smokeshow of a deal and I'll admit I was wrong and take back anything negative I've said about you. And sing songs of praise to you daily.
Comment by Redbaron2211 on Jan 14, 2022 10:05am
I will give them benefit of the doubt.   Something doesn't add up with Sernova acting like Fort Knox post data release.  Can't even make the local paper this year, they obviously are putting in no effort to get the word out.  Only thing I can think of is they have a deal in the bag and any attempt at promo is irrelevant.  If that's not the case, I will ...more  
Comment by BioTeck on Jan 14, 2022 1:01pm
They are always Fort Nots. No word on anything from conformal coating to the collaborations to hemo to thyroid to TSX listing. DOesn't matter what kindo of deal you have in the making, you should always keep your share price up. Deals can always go south (like our share price).  You can keep making excuses for them though, it's what you do best. You sure you haven't been hired as ...more  
Comment by Redbaron2211 on Jan 14, 2022 1:11pm
Bio you know just as well as I do this is not normal after a big NR.  If they already have terms agreed upon, then it's not so important to keep SP up.   I'm definitely not in this for the salary.    
Comment by BioTeck on Jan 14, 2022 1:35pm
OK, so if that is the case,  then what is the point of hiring 3 different IR entities? Also, you're guessing this is the reason, what if it isn't?
Comment by Redbaron2211 on Jan 14, 2022 1:59pm
As I said, can't see any other reason why they wouldn't promote, especially after hiring 3 IR entities.    
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities